🇧🇪 Belgium · EU Public Tender
Spécialités pharmaceutiques à base de Olaparib, Osimertinib, Durvalumab, Acalabrutinib, Benralizumab, Palivizumab, Cyclosilicate de zirconium sodique, Dapagliflozine, Ticagrélor, Exénatide , Goséréline et Fumarate de formotérol dihydraté, bromure de glycopyrronium et budésonide.
🏛️ Association iris-Achats · 📍 Saint-Gilles
3.5M €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | AstraZeneca |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.